A randomised trial comparing 4.8 vs 2.4g/day of oral mesalazine for maintenance of remission in ulcerative colitis
Pica, Roberta, Cassieri, Claudio, Cocco, Andrea, Zippi, Maddalena, Marcheggiano, Adriana, De Nitto, Daniela, Avallone, Eleonora Veronica, Crispino, Pietro, Occhigrossi, Giuseppe, Paoluzi, PaoloLanguage:
english
Journal:
Digestive and Liver Disease
DOI:
10.1016/j.dld.2015.07.011
Date:
July, 2015
File:
PDF, 584 KB
english, 2015